Logo image of VENU

VENU HOLDING CORP (VENU) Stock Fundamental Analysis

USA - NYSEARCA:VENU - US92333E1047 - Common Stock

12.81 USD
-0.09 (-0.7%)
Last: 9/30/2025, 8:00:00 PM
12.81 USD
0 (0%)
After Hours: 9/30/2025, 8:00:00 PM
Fundamental Rating

2

VENU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of VENU is average, but there are quite some concerns on its profitability. While showing a medium growth rate, VENU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VENU has reported negative net income.
In the past year VENU has reported a negative cash flow from operations.
VENU Yearly Net Income VS EBIT VS OCF VS FCFVENU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -15.41%, VENU is doing worse than 87.41% of the companies in the same industry.
VENU has a worse Return On Equity (-41.86%) than 63.70% of its industry peers.
Industry RankSector Rank
ROA -15.41%
ROE -41.86%
ROIC N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VENU Yearly ROA, ROE, ROICVENU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

With a Gross Margin value of 46.51%, VENU perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
VENU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VENU Yearly Profit, Operating, Gross MarginsVENU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

VENU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VENU has more shares outstanding
VENU has a worse debt/assets ratio than last year.
VENU Yearly Shares OutstandingVENU Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
VENU Yearly Total Debt VS Total AssetsVENU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.72, we must say that VENU is in the distress zone and has some risk of bankruptcy.
VENU has a Altman-Z score (1.72) which is in line with its industry peers.
VENU has a Debt/Equity ratio of 0.69. This is a neutral value indicating VENU is somewhat dependend on debt financing.
VENU has a Debt to Equity ratio of 0.69. This is in the better half of the industry: VENU outperforms 65.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACCN/A
WACC8.76%
VENU Yearly LT Debt VS Equity VS FCFVENU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M

2.3 Liquidity

VENU has a Current Ratio of 2.72. This indicates that VENU is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of VENU (2.72) is better than 93.33% of its industry peers.
VENU has a Quick Ratio of 2.70. This indicates that VENU is financially healthy and has no problem in meeting its short term obligations.
VENU has a Quick ratio of 2.70. This is amongst the best in the industry. VENU outperforms 94.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.7
VENU Yearly Current Assets VS Current LiabilitesVENU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for VENU have decreased strongly by -186.29% in the last year.
Looking at the last year, VENU shows a very strong growth in Revenue. The Revenue has grown by 41.57%.
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%

3.2 Future

The Earnings Per Share is expected to grow by 32.39% on average over the next years. This is a very strong growth
VENU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 111.85% yearly.
EPS Next Y-7.81%
EPS Next 2Y71.85%
EPS Next 3Y32.39%
EPS Next 5YN/A
Revenue Next Year80.2%
Revenue Next 2Y208.56%
Revenue Next 3Y111.85%
Revenue Next 5YN/A

3.3 Evolution

VENU Yearly Revenue VS EstimatesVENU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 50M 100M 150M
VENU Yearly EPS VS EstimatesVENU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

VENU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 20.59 indicates a rather expensive valuation of VENU.
60.74% of the companies in the same industry are more expensive than VENU, based on the Price/Forward Earnings ratio.
VENU is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 20.59
VENU Price Earnings VS Forward Price EarningsVENU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VENU Per share dataVENU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as VENU's earnings are expected to grow with 32.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.85%
EPS Next 3Y32.39%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VENU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VENU HOLDING CORP

NYSEARCA:VENU (9/30/2025, 8:00:00 PM)

After market: 12.81 0 (0%)

12.81

-0.09 (-0.7%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)N/A N/A
Inst Owners4.36%
Inst Owner Change60.48%
Ins Owners38.11%
Ins Owner Change-0.64%
Market Cap553.26M
Analysts82.22
Price Target16.08 (25.53%)
Short Float %1.03%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.29%
PT rev (3m)11.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)13.02%
EPS NY rev (3m)-253.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-11.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.59
P/S 31.81
P/FCF N/A
P/OCF N/A
P/B 7.06
P/tB 7.08
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)0.62
Fwd EY4.86%
FCF(TTM)-2.04
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.4
BVpS1.81
TBVpS1.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE -41.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.51%
FCFM N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1934.1%
Cap/Sales 492.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.72
Quick Ratio 2.7
Altman-Z 1.72
F-Score2
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)1444.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)249.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
EPS Next Y-7.81%
EPS Next 2Y71.85%
EPS Next 3Y32.39%
EPS Next 5YN/A
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%
Revenue Next Year80.2%
Revenue Next 2Y208.56%
Revenue Next 3Y111.85%
Revenue Next 5YN/A
EBIT growth 1Y-145.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-24.26%
EBIT Next 3Y65.75%
EBIT Next 5YN/A
FCF growth 1Y-90.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.06%
OCF growth 3YN/A
OCF growth 5YN/A